Key Issues as Wearable Digital Health Technologies Enter Clinical Care | NEJM
Review Article from The New England Journal of Medicine — Key Issues as Wearable Digital Health Technologies Enter Clinical Care
Review Article from The New England Journal of Medicine — Key Issues as Wearable Digital Health Technologies Enter Clinical Care
Despite being absolutely clear that she wanted a quick, painless end of life, a geriatrician’s elderly mother receives aggressive care. How can we ensure that…
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But…
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis through ex vivo clustered regularly interspaced short palindromic repeats (CRISPR)–Ca…
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But…
A 47-year-old man presented with 2-day history of weakness and fever. Laboratory studies showed pancytopenia. A bone marrow biopsy showed promyelocytes with abundant intracellular rods.
If you are thinking about going back to work after cancer treatment, we have information about how to manage the transition and getting employer support.
Discover the Interventional Oncology Foundation Course by CIRSE, a key opportunity for young interventionists exploring oncology treatments
The combination of trastuzumab and pertuzumab (HP) as part of a taxane-based regimen has shown benefit in the adjuvant and metastatic HER2+ breast cancer setting.…
The pathological classification of endometrial carcinomas, one of the cornerstones in patient clinical management, has traditionally been based on morphologic features. However, this classification system…